The Second Sight visual prosthesis maker announced the implementation of a visual stimulator wireless, named Orion 1, a female patient 30 years. This test was conducted as part of a study conducted by the University of California at Los Angeles (UCLA) and the young woman was able to distinguish colors and bright spots. The next step is to obtain authorization from the Federal Agency for Medicines (FDA) for clinical trials.
Orion 1 stimulates the visual cortex
According to the surgeon Nader Pouratian, stimulation of the visual cortex could restore vision for blind people become more autonomous and thus improve their quality of life. Through this trial and preclinical work, the Second Sight manufacturer can register their invention with the FDA early next year. The blind can not benefit epiretinal Argus II prosthesis, the first implantation of a human subject is cause for hope for the research team. Whatever the reasons that caused their blindness (glaucoma, cancer, trauma ...), the useful vision of the blind would be restored. Even if the camera was not yet integrated in this trial, Robert Greenberg, an analyst in the company head believes they are "on track".
Second Sight hopes to obtain IDE approval in order to conduct a clinical trial for the entire device. In addition to the stimulator, Orion 1 also includes a camera and goggles. If all goes as planned, a larger clinical study is still needed before an international marketing.
0 comments:
Post a Comment